Deepak Chadha - 05 May 2022 Form 4 Insider Report for Brickell Biotech, Inc.

Role: Chief Research & Dev. Officer
Signature: /s/ Christine G. Long, Attorney-in-Fact for Deepak Chadha (power of attorney previously filed)
Issuer symbol: N/A
Transactions as of: 05 May 2022
Net transactions value: $0
Form type: 4
Filing time: 09 May 2022, 16:17:07 UTC
Previous filing: 14 Jun 2021
Next filing: 26 Jan 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FRTX	Stock Option (right to buy)	Award	$0	+325,000		$0.000000	325,000	05 May 2022	Common Stock	325,000	$0.2600	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock options will vest 25% on the first anniversary of the grant date, and the remainder will vest in equal monthly installments over the following three years.